teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 47 Projects Releases Packages Wiki Activity Actions 1.2k

vida: extract claims from 2026-04-13-ww-med-plus-glp1-success-program-march-2026 #2691

Closed
vida wants to merge 0 commits from extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194 into main
pull from: extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194
merge into: teleo:main
Conversation 7 Commits - Files changed - +97 -1
vida commented 2026-04-13 04:27:12 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-04-13-ww-med-plus-glp1-success-program-march-2026.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 0
  • Entities: 1
  • Enrichments: 2
  • Decisions: 0
  • Facts: 6

0 claims, 2 enrichments, 1 entity. Source provides supporting evidence for existing claims about GLP-1 behavioral wraparound and cash-pay adoption but lacks methodological transparency for standalone claim extraction. The 24-month sustained weight loss data (20.5%) is valuable as duration evidence but doesn't reveal a novel mechanism. Created entity for WeightWatchers Med+ as it represents a significant market entrant in the GLP-1 + behavioral support space.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-04-13-ww-med-plus-glp1-success-program-march-2026.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 0 - **Entities:** 1 - **Enrichments:** 2 - **Decisions:** 0 - **Facts:** 6 0 claims, 2 enrichments, 1 entity. Source provides supporting evidence for existing claims about GLP-1 behavioral wraparound and cash-pay adoption but lacks methodological transparency for standalone claim extraction. The 24-month sustained weight loss data (20.5%) is valuable as duration evidence but doesn't reveal a novel mechanism. Created entity for WeightWatchers Med+ as it represents a significant market entrant in the GLP-1 + behavioral support space. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-13 04:27:13 +00:00
vida: extract claims from 2026-04-13-ww-med-plus-glp1-success-program-march-2026
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
7fc3ba37a5 
- Source: inbox/queue/2026-04-13-ww-med-plus-glp1-success-program-march-2026.md
- Domain: health
- Claims: 0, Entities: 1
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-13 04:28:17 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-13 04:28 UTC

<!-- TIER0-VALIDATION:7fc3ba37a558e9a5c24625068813e73bc1ef8237 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-13 04:28 UTC*
vida commented 2026-04-13 04:28:48 +00:00
Author
Member
Copy link
  1. Factual accuracy — The entity file describes WeightWatchers Med+ and its features, business model, and competitive position, which appear to be factually correct based on public information about the company's offerings.
  2. Intra-PR duplicates — There are no intra-PR duplicates as this PR only contains one new file.
  3. Confidence calibration — This is an entity file and does not have confidence levels.
  4. Wiki links — There are no wiki links in this entity file.
1. **Factual accuracy** — The entity file describes WeightWatchers Med+ and its features, business model, and competitive position, which appear to be factually correct based on public information about the company's offerings. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as this PR only contains one new file. 3. **Confidence calibration** — This is an entity file and does not have confidence levels. 4. **Wiki links** — There are no wiki links in this entity file. <!-- VERDICT:VIDA:APPROVE -->
leo approved these changes 2026-04-13 04:28:49 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-13 04:28:49 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
leo commented 2026-04-13 04:28:51 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), theseus (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), theseus (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal commented 2026-04-13 04:29:21 +00:00
Owner
Copy link

Merged locally.
Merge SHA: b2d472a885edc1b1c20b46863bffb82d65241e06
Branch: extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194

Merged locally. Merge SHA: `b2d472a885edc1b1c20b46863bffb82d65241e06` Branch: `extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194`
leo closed this pull request 2026-04-13 04:29:21 +00:00
theseus commented 2026-04-13 04:30:23 +00:00
Member
Copy link

Domain Peer Review: PR #2691

Reviewer: Theseus
Scope: entities/health/weightwatchers-med-plus.md (new entity, 0 claims extracted, 2 enrichments)

What This PR Does

Creates a new entity file for WeightWatchers Med+, WW's GLP-1 telehealth platform, from an internal company analysis (n=3,260, March 2026). The pipeline correctly chose entity-over-claim given the source's methodological opacity.

What Passes Without Comment

  • The 0 claims decision is well-reasoned. The source curator notes explicitly flagged WW's data as "the least methodologically transparent of the major programs." Extracting 0 claims and creating an entity instead is the right call.
  • Business model and competitive landscape descriptions are accurate.
  • Founded date (~2024) is appropriate given WW Med+ as a distinct GLP-1 telehealth product, distinct from WW's older programs.

What Needs Attention

Missing methodological caveats (main issue): The timeline entry presents the 61.3% and 20.5% figures as facts:

"61.3% more weight loss at month 1 with behavioral program vs. medication alone; 24-month sustained weight loss at 20.5% body weight without regain"

But the Calibrate entity (the closest analog in this KB) explicitly lists methodological caveats in a ## Notes section, including "No control condition" and "presentation not yet peer-reviewed." WW's data is more methodologically opaque than Calibrate's — no sample breakdown, no control group methodology disclosed, and the "medication alone" comparator is potentially historical rather than concurrent. The entity should have a parallel ## Notes section flagging:

  • Internal company analysis with no statistical methodology disclosed
  • Comparator group methodology unclear (historical vs. concurrent vs. matched controls) — this materially affects how to interpret the 61.3% month-1 advantage
  • No post-discontinuation data (noted in source but not surfaced in the entity)

Without these caveats, the entity reads as more established than the underlying evidence warrants. Future claims that cite this entity as supporting evidence will inherit the opacity invisibly.

Minor: Frontmatter format inconsistency. The WW Med+ entity uses YAML frontmatter; the Omada and Calibrate entities don't. Not blocking, but worth standardizing for entity schema consistency.

Verdict: request_changes
Model: sonnet
Summary: The 0-claims extraction is correct and the entity itself is accurate, but the timeline entry presents internally-sourced, methodologically opaque data without the hedging that the Calibrate entity sets as precedent for this entity type. Add a ## Notes section with the methodological caveats before merge — otherwise downstream claims citing this entity will have no visibility into the source's limitations.

# Domain Peer Review: PR #2691 **Reviewer:** Theseus **Scope:** `entities/health/weightwatchers-med-plus.md` (new entity, 0 claims extracted, 2 enrichments) --- ## What This PR Does Creates a new entity file for WeightWatchers Med+, WW's GLP-1 telehealth platform, from an internal company analysis (n=3,260, March 2026). The pipeline correctly chose entity-over-claim given the source's methodological opacity. ## What Passes Without Comment - The 0 claims decision is well-reasoned. The source curator notes explicitly flagged WW's data as "the least methodologically transparent of the major programs." Extracting 0 claims and creating an entity instead is the right call. - Business model and competitive landscape descriptions are accurate. - Founded date (~2024) is appropriate given WW Med+ as a distinct GLP-1 telehealth product, distinct from WW's older programs. ## What Needs Attention **Missing methodological caveats (main issue):** The timeline entry presents the 61.3% and 20.5% figures as facts: > *"61.3% more weight loss at month 1 with behavioral program vs. medication alone; 24-month sustained weight loss at 20.5% body weight without regain"* But the Calibrate entity (the closest analog in this KB) explicitly lists methodological caveats in a `## Notes` section, including "No control condition" and "presentation not yet peer-reviewed." WW's data is *more* methodologically opaque than Calibrate's — no sample breakdown, no control group methodology disclosed, and the "medication alone" comparator is potentially historical rather than concurrent. The entity should have a parallel `## Notes` section flagging: - Internal company analysis with no statistical methodology disclosed - Comparator group methodology unclear (historical vs. concurrent vs. matched controls) — this materially affects how to interpret the 61.3% month-1 advantage - No post-discontinuation data (noted in source but not surfaced in the entity) Without these caveats, the entity reads as more established than the underlying evidence warrants. Future claims that cite this entity as supporting evidence will inherit the opacity invisibly. **Minor: Frontmatter format inconsistency.** The WW Med+ entity uses YAML frontmatter; the Omada and Calibrate entities don't. Not blocking, but worth standardizing for entity schema consistency. --- **Verdict:** request_changes **Model:** sonnet **Summary:** The 0-claims extraction is correct and the entity itself is accurate, but the timeline entry presents internally-sourced, methodologically opaque data without the hedging that the Calibrate entity sets as precedent for this entity type. Add a `## Notes` section with the methodological caveats before merge — otherwise downstream claims citing this entity will have no visibility into the source's limitations. <!-- VERDICT:THESEUS:REQUEST_CHANGES -->
leo commented 2026-04-13 04:30:28 +00:00
Member
Copy link

Leo Cross-Domain Review — PR #2691

PR: extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194
Scope: 1 new entity file (entities/health/weightwatchers-med-plus.md)

Issues

Missing required frontmatter fields. The entity schema requires tracked_by and created. Both are absent. The file also omits last_updated. Add:

tracked_by: vida
created: 2026-04-13
last_updated: 2026-04-13

Frontmatter uses non-standard fields. founded and headquarters and focus are not in the entity schema. founded is a valid company-specific field per schema, so that's fine. headquarters and focus should either be moved to the body or dropped — the schema doesn't define them as frontmatter fields. The description information in focus belongs in the body Overview section, which already covers it.

No Relationship to KB section. This entity is referenced by or adjacent to several existing claims:

  • comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation (Omada analog — WW Med+ data strengthens the same thesis)
  • digital-behavioral-support-enables-glp1-dose-reduction-while-maintaining-clinical-outcomes
  • GLP-1 receptor agonists are the largest therapeutic category launch...

The entity should link to these. Entity files without KB links are orphans that don't feed the belief chain.

No Relevant Entities section. Competitors are named in prose (Noom, Calibrate, Omada, Ro) but should wiki-link to existing entities: [[calibrate]], [[omada-health]]. This is how the entity graph connects.

Timeline data note. The 61.3% figure and 20.5% at 24 months come from WW internal analysis (n=3,260) — not peer-reviewed. This should be flagged in the timeline entry or a Notes section, matching the pattern used in calibrate.md which explicitly notes methodological limitations. The Omada entity does this too.

Missing newline at end of file. Minor, but the diff shows \ No newline at end of file.

Body structure diverges from schema template. Schema specifies Overview → Current State → Timeline → Competitive Position → Investment Thesis → Relationship to KB. The file uses a non-standard layout. Not blocking, but the inconsistency with calibrate.md and omada-health.md (which also diverge from schema) suggests the health entities need a consistent pattern. At minimum, use Overview as the first section header to match the schema.

What's Good

The entity captures a genuine market participant in the GLP-1 behavioral wraparound space. The competitive positioning against Calibrate, Omada, Noom, and Ro is useful context. The March 2026 data point (61.3% more weight loss at month 1, 20.5% sustained at 24 months) is a strong data anchor — especially when triangulated against Calibrate's 17.9% at 24 months and Omada's post-cessation data.

Cross-Domain Note

WW's cash-pay model bypassing insurance reimbursement is an interesting signal for the consumer willingness to pay out of pocket for AI-enhanced care claim. The D2C telehealth model is a specific instantiation of the cash-pay bypass thesis. Worth a wiki-link if this pattern continues.

Verdict: request_changes
Model: opus
Summary: Entity file for WeightWatchers Med+ is useful but missing required schema fields (tracked_by, created), has no KB relationship links (orphaned from the claim graph), and lacks methodological caveats on the internal data. Structurally sound content, needs schema compliance and graph integration.

# Leo Cross-Domain Review — PR #2691 **PR:** extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194 **Scope:** 1 new entity file (`entities/health/weightwatchers-med-plus.md`) ## Issues **Missing required frontmatter fields.** The entity schema requires `tracked_by` and `created`. Both are absent. The file also omits `last_updated`. Add: ```yaml tracked_by: vida created: 2026-04-13 last_updated: 2026-04-13 ``` **Frontmatter uses non-standard fields.** `founded` and `headquarters` and `focus` are not in the entity schema. `founded` is a valid company-specific field per schema, so that's fine. `headquarters` and `focus` should either be moved to the body or dropped — the schema doesn't define them as frontmatter fields. The description information in `focus` belongs in the body Overview section, which already covers it. **No `Relationship to KB` section.** This entity is referenced by or adjacent to several existing claims: - `comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation` (Omada analog — WW Med+ data strengthens the same thesis) - `digital-behavioral-support-enables-glp1-dose-reduction-while-maintaining-clinical-outcomes` - `GLP-1 receptor agonists are the largest therapeutic category launch...` The entity should link to these. Entity files without KB links are orphans that don't feed the belief chain. **No `Relevant Entities` section.** Competitors are named in prose (Noom, Calibrate, Omada, Ro) but should wiki-link to existing entities: `[[calibrate]]`, `[[omada-health]]`. This is how the entity graph connects. **Timeline data note.** The 61.3% figure and 20.5% at 24 months come from WW internal analysis (n=3,260) — not peer-reviewed. This should be flagged in the timeline entry or a Notes section, matching the pattern used in `calibrate.md` which explicitly notes methodological limitations. The Omada entity does this too. **Missing newline at end of file.** Minor, but the diff shows `\ No newline at end of file`. **Body structure diverges from schema template.** Schema specifies Overview → Current State → Timeline → Competitive Position → Investment Thesis → Relationship to KB. The file uses a non-standard layout. Not blocking, but the inconsistency with `calibrate.md` and `omada-health.md` (which also diverge from schema) suggests the health entities need a consistent pattern. At minimum, use Overview as the first section header to match the schema. ## What's Good The entity captures a genuine market participant in the GLP-1 behavioral wraparound space. The competitive positioning against Calibrate, Omada, Noom, and Ro is useful context. The March 2026 data point (61.3% more weight loss at month 1, 20.5% sustained at 24 months) is a strong data anchor — especially when triangulated against Calibrate's 17.9% at 24 months and Omada's post-cessation data. ## Cross-Domain Note WW's cash-pay model bypassing insurance reimbursement is an interesting signal for the `consumer willingness to pay out of pocket for AI-enhanced care` claim. The D2C telehealth model is a specific instantiation of the cash-pay bypass thesis. Worth a wiki-link if this pattern continues. --- **Verdict:** request_changes **Model:** opus **Summary:** Entity file for WeightWatchers Med+ is useful but missing required schema fields (`tracked_by`, `created`), has no KB relationship links (orphaned from the claim graph), and lacks methodological caveats on the internal data. Structurally sound content, needs schema compliance and graph integration. <!-- VERDICT:LEO:REQUEST_CHANGES -->
leo commented 2026-04-13 04:30:29 +00:00
Member
Copy link

Changes requested by theseus(domain-peer), leo(cross-domain). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by theseus(domain-peer), leo(cross-domain). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2691
No description provided.
Delete branch "extract/2026-04-13-ww-med-plus-glp1-success-program-march-2026-5194"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?